A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. | ...

James Ford on his leadership maxims, how he deals with the pressures of life as a GC and the highlights of three decades at ...

Last month marked a little-known legal anniversary with big-time consequences for Americans’ public health: Back in July 2012, British biopharmaceutical giant GlaxoSmithKline reached a ...